BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10331507)

  • 1. Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation.
    Hori Y; Wada H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Nishii K; Tamaki S; Nishikawa M; Deguchi K; Minami N; Shiku H
    Am J Hematol; 1999 May; 61(1):21-5. PubMed ID: 10331507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation.
    Wada H; Ohiwa M; Kaneko T; Tamaki S; Tanigawa M; Shirakawa S; Koyama M; Hayashi T; Suzuki K
    Am J Hematol; 1992 Jan; 39(1):20-4. PubMed ID: 1311143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
    Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
    Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
    Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Mori Y; Wada H; Okugawa Y; Tamaki S; Nakasaki T; Watanabe R; Gabazza EC; Nishikawa M; Minami N; Shiku H
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):5-9. PubMed ID: 11190905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
    Kobayashi M; Wada H; Wakita Y; Shimura M; Nakase T; Hiyoyama K; Nagaya S; Minami N; Nakano T; Shiku H
    Thromb Haemost; 1995 Jan; 73(1):10-4. PubMed ID: 7740478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
    Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
    Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation.
    Hiyoyama K; Wada H; Shimura M; Nakasaki T; Katayama N; Nishikawa M; Shiku H; Tahara T; Kato T
    Blood Coagul Fibrinolysis; 1997 Sep; 8(6):345-9. PubMed ID: 9351524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury.
    Nguyen TC; Cruz MA; Carcillo JA
    Crit Care Clin; 2015 Oct; 31(4):661-74. PubMed ID: 26410136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble fas levels correlate with multiple organ dysfunction severity, survival and nitrate levels, but not with cellular apoptotic markers in critically ill patients.
    Papathanassoglou ED; Moynihan JA; Vermillion DL; McDermott MP; Ackerman MH
    Shock; 2000 Aug; 14(2):107-12. PubMed ID: 10947151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure.
    Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
    Am J Hematol; 1991 Dec; 38(4):281-7. PubMed ID: 1660674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein C levels in disseminated intravascular coagulation and thrombotic thrombocytopenic purpura: its correlation with other coagulation parameters.
    Takahashi H; Takakuwa E; Yoshino N; Hanano M; Shibata A
    Thromb Haemost; 1985 Aug; 54(2):445-9. PubMed ID: 3841232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases.
    Habe K; Wada H; Ito-Habe N; Hatada T; Matsumoto T; Ohishi K; Maruyama K; Imai H; Mizutani H; Nobori T
    Thromb Res; 2012 May; 129(5):598-602. PubMed ID: 22070827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma soluble fas and soluble fas ligand in chronic glomerulonephritis.
    Sano H; Asano K; Minatoguchi S; Hiraoka J; Fujisawa K; Nishigaki K; Yasuda N; Kumada H; Takemura M; Ohashi H; Seishima M; Fujiwara T; Fujiwara H
    Nephron; 1998 Oct; 80(2):153-61. PubMed ID: 9736812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome.
    Doughty L; Clark RS; Kaplan SS; Sasser H; Carcillo J
    Pediatr Res; 2002 Dec; 52(6):922-7. PubMed ID: 12438671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet count and prothrombin time help distinguish thrombotic thrombocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults.
    Park YA; Waldrum MR; Marques MB
    Am J Clin Pathol; 2010 Mar; 133(3):460-5. PubMed ID: 20154285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma P-selectin is increased in thrombotic consumptive platelet disorders.
    Chong BH; Murray B; Berndt MC; Dunlop LC; Brighton T; Chesterman CN
    Blood; 1994 Mar; 83(6):1535-41. PubMed ID: 7510145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: role of neutrophil elastase.
    Gando S; Nakanishi Y; Kameue T; Nanzaki S
    J Trauma; 1995 Oct; 39(4):660-4. PubMed ID: 7473950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome.
    Masri C; Proulx F; Toledano B; Clermont MJ; Mariscalco MM; Seidman EG; Carcillo J
    Am J Kidney Dis; 2000 Oct; 36(4):687-94. PubMed ID: 11007669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.